COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
Nanotechnology for MedicineAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Sian Bunnage. BP Lectures 2013 Nanometer-sized carbon carriers, hydrophilic carbon clusters (HCCs), have been developed for targeted drug delivery for cancer chemotherapy. In vitro and in vivo applications in head and neck, breast and brain (glioblastoma) cancers will be shown. The HCCs and related carbon nanoparticles are also potent and selective antioxidants, able to annihilate large amounts of superoxide while converting the superoxide to molecular oxygen with no downstream radical formation. Moreover, the nanoparicles do not react with the important vasodilator nitric oxide. Extensive in vitro, electron paramagnetic resonance and in vivo studies have been done. Applications in the treatment of traumatic brain injury/hemorrhagic shock and stroke will be discussed. This talk is part of the Department of Chemistry series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsAMOP/TCM Seminar DevBio CUPORTSS quantitative history seminar New Hall Art Collection Birational geometry seminarOther talksCambridge - Corporate Finance Theory Symposium September 2017 - Day 2 Overview of Research Process Part IIB Poster Presentations CANCELLED Jennifer Luff: Secrets, Lies, and the 'Special Relationship' in the Early Cold War Simulating wave propagation in elastic systems using the Finite-Difference-Time-Domain method Bayesian deep learning 100 Problems around Scalar Curvature 'Politics in Uncertain Times: What will the world look like in 2050 and how do you know? Café Synthetique: Graduate Talks! Horizontal transfer of antimicrobial resistance drives multi-species population level epidemics |